- Home
- Publications
- Publication Search
- Publication Details
Title
SEOM clinical guidelines in metastatic breast cancer 2015
Authors
Keywords
Metastatic breast cancer, Clinical guidelines, Chemotherapy, Hormonal therapy, Anti-HER2 therapy
Journal
Clinical & Translational Oncology
Volume 17, Issue 12, Pages 946-955
Publisher
Springer Nature
Online
2015-12-18
DOI
10.1007/s12094-015-1476-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 361PDINTERIM SAFETY AND EFFICACY OF PERTUZUMAB, TRASTUZUMAB AND VINORELBINE FOR FIRST-LINE (1L) TREATMENT OF PATIENTS (PTS) WITH HER2-POSITIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER (MBC)
- (2017) M. Andersson et al. ANNALS OF ONCOLOGY
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
- (2015) Rajendra Badwe et al. LANCET ONCOLOGY
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
- (2014) F. Cardoso et al. ANNALS OF ONCOLOGY
- Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study
- (2014) Eduardo Martínez de Dueñas et al. BREAST CANCER RESEARCH AND TREATMENT
- New Strategies for Triple-Negative Breast Cancer--Deciphering the Heterogeneity
- (2014) I. A. Mayer et al. CLINICAL CANCER RESEARCH
- A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
- (2014) M Pennant et al. HEALTH TECHNOLOGY ASSESSMENT
- Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
- (2014) Ian E Krop et al. LANCET ONCOLOGY
- Both Carboplatin and Bevacizumab Improve Pathological Complete Remission Rate in Neoadjuvant Treatment of Triple Negative Breast Cancer: A Meta-Analysis
- (2014) Xiao-song Chen et al. PLoS One
- Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer
- (2013) Joachim Rom et al. ANTI-CANCER DRUGS
- A Systematic Review of Vinorelbine for the Treatment of Breast Cancer
- (2013) Ying-Chun Xu et al. Breast Journal
- Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline
- (2013) M. J. Gil-Gil et al. Clinical & Translational Oncology
- Clinical application of18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in breast cancer
- (2013) M. Bernsdorf et al. CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING
- Treatment of breast cancer brain metastases
- (2013) Silvia Hofer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- When to order a biopsy to characterise a metastatic relapse in breast cancer
- (2012) T. Foukakis et al. ANNALS OF ONCOLOGY
- Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
- (2012) L. Zhang et al. CLINICAL CANCER RESEARCH
- Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study
- (2012) Kimberly L. Blackwell et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression
- (2012) Fausto Petrelli et al. MEDICAL ONCOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
- (2011) J. Huober et al. BREAST
- HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis
- (2011) Nehmat Houssami et al. BREAST CANCER RESEARCH AND TREATMENT
- Oral vinorelbine in metastatic breast cancer: A review of current clinical trial results
- (2011) Matti Aapro et al. CANCER TREATMENT REVIEWS
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Heterogeneity of Metabolic Response to Systemic Therapy in Metastatic Breast Cancer Patients
- (2010) V. Huyge et al. CLINICAL ONCOLOGY
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature
- (2009) Jetske Ruiterkamp et al. BREAST CANCER RESEARCH AND TREATMENT
- Capecitabine and vinorelbine in metastatic breast cancer
- (2009) Arlene Chan et al. EUROPEAN JOURNAL OF CANCER
- Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
- (2009) Stephen Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
- (2009) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
- (2009) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors in 1038 women with metastatic breast cancer
- (2008) R. Largillier et al. ANNALS OF ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started